KalVista Pharmaceuticals, Inc. (KALV)

Latest Insider Confidence Score

2026Q1

48.9
Bearish

Company insider confidence (by quarter)

2015Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Shah Nimish P 10% Owner 5,303,985 Apr 11, 2025
Venrock Healthcare Capital Partners III, L.P. 10% Owner 5,303,985 Apr 11, 2025
VHCP Co-Investment Holdings III, LLC 10% Owner 5,303,985 Apr 11, 2025
VHCP Management EG, LLC 10% Owner 5,303,985 Apr 11, 2025
Venrock Healthcare Capital Partners EG, L.P. 10% Owner 5,303,985 Apr 11, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 21, 2026 Feb 24, 2026 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 42.5 -5,354 -3.71% ✗ $83.3K
Feb 21, 2026 Feb 24, 2026 Palleiko Benjamin L CEO Sell 42.5 -10,034 -2.22% ✗ $156.2K
Feb 21, 2026 Feb 24, 2026 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 42.5 -4,347 -1.88% ✗ $67.7K
Feb 21, 2026 Feb 24, 2026 Sweeny Nicole Chief Commercial Officer Sell 42.5 -3,975 -7.80% ✗ $61.9K
Feb 21, 2026 Feb 24, 2026 Piekos Brian CFO Sell 46.3 -1,767 -11.38% ✗ $27.5K
Feb 17, 2026 Feb 19, 2026 Palleiko Benjamin L CEO Sell 51.3 -1,038 -0.24% ✗ $15.6K
Feb 17, 2026 Feb 19, 2026 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 48.8 -1,163 -0.87% ✗ $17.4K
Feb 17, 2026 Feb 19, 2026 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 51.3 -1,109 -0.49% ✗ $16.6K
Feb 11, 2026 Feb 13, 2026 Palleiko Benjamin L CEO Sell 45.0 -3,354 -0.78% ✗ $52.7K
Jan 16, 2026 Jan 21, 2026 Arif Bilal Chief Operations Officer Neutral 52.5 - 0.00% ✗ -
Jan 16, 2026 Jan 21, 2026 Sweeny Nicole Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jan 16, 2026 Jan 21, 2026 Piekos Brian CFO Neutral 52.5 - 0.00% ✗ -
Jan 16, 2026 Jan 21, 2026 Audhya Paul K. CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Jan 16, 2026 Jan 21, 2026 Palleiko Benjamin L CEO Neutral 52.5 - 0.00% ✗ -
Dec 6, 2025 Dec 9, 2025 Palleiko Benjamin L CEO Sell 42.5 -7,294 -1.69% ✗ $120.4K
Nov 21, 2025 Dec 4, 2025 Sweeny Nicole Chief Commercial Officer Sell 42.5 -3,813 -8.76% ✗ $51.3K
Nov 21, 2025 Nov 26, 2025 Piekos Brian CFO Sell 42.5 -4,471 -29.81% ✗ $60.1K
Nov 21, 2025 Nov 26, 2025 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 42.5 -4,331 -1.90% ✗ $58.3K
Nov 21, 2025 Nov 26, 2025 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 42.5 -5,296 -3.86% ✗ $71.2K
Nov 21, 2025 Nov 26, 2025 Palleiko Benjamin L CEO Sell 42.5 -10,940 -2.56% ✗ $147.2K
Nov 20, 2025 Nov 21, 2025 Yea Christopher CHIEF DEVELOPMENT OFFICER Neutral 52.5 - 0.00% ✗ -
Nov 17, 2025 Nov 19, 2025 Palleiko Benjamin L CEO Sell 42.5 -4,466 -1.09% ✗ $64.7K
Nov 17, 2025 Nov 19, 2025 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 46.3 -2,683 -1.97% ✗ $38.8K
Nov 17, 2025 Nov 19, 2025 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 46.3 -3,075 -2.38% ✗ $44.5K
Nov 11, 2025 Nov 13, 2025 Palleiko Benjamin L CEO Sell 48.8 -3,328 -0.83% ✗ $38.4K
Oct 8, 2025 Oct 8, 2025 Arif Bilal Chief Operations Officer Neutral 52.5 - 0.00% ✗ -
Oct 8, 2025 Arif Bilal Chief Operations Officer Neutral 52.5 - 0.00% ✗ -
Oct 1, 2025 Oct 2, 2025 Pereira Brian JG Director Neutral 52.5 - 0.00% ✗ -
Oct 1, 2025 Oct 2, 2025 Stuart Nancy Director Neutral 52.5 - 0.00% ✗ -
Oct 1, 2025 Oct 2, 2025 Treanor Patrick Director Neutral 52.5 - 0.00% ✗ -
Oct 1, 2025 Oct 2, 2025 Fairey William Director Neutral 52.5 - 0.00% ✗ -
Oct 1, 2025 Oct 2, 2025 Unkart Edward W Director Neutral 52.5 - 0.00% ✗ -
Oct 1, 2025 Oct 2, 2025 Sensenig Bethany Director Neutral 52.5 - 0.00% ✗ -
Oct 2, 2025 Sensenig Bethany Director Neutral 52.5 - 0.00% ✗ -
Sep 6, 2025 Sep 9, 2025 Palleiko Benjamin L CEO Sell 42.5 -7,294 -1.81% ✗ $115.5K
Aug 22, 2025 Aug 26, 2025 Sweeny Nicole Chief Commercial Officer Sell 46.3 -1,480 -4.38% ✗ $19.9K
Aug 22, 2025 Aug 26, 2025 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 46.3 -1,954 -1.46% ✗ $26.2K
Aug 22, 2025 Aug 26, 2025 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 46.3 -2,336 -1.87% ✗ $31.3K
Aug 21, 2025 Aug 25, 2025 Sweeny Nicole Chief Commercial Officer Sell 46.3 -1,864 -6.08% ✗ $24.6K
Aug 25, 2025 Sweeny Nicole Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Aug 21, 2025 Aug 25, 2025 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 46.3 -2,362 -1.77% ✗ $31.2K
Aug 21, 2025 Aug 25, 2025 Palleiko Benjamin L CEO Sell 42.5 -10,940 -2.75% ✗ $144.7K
Aug 21, 2025 Aug 25, 2025 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 46.3 -2,942 -2.40% ✗ $38.9K
Aug 17, 2025 Aug 19, 2025 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 46.3 -2,649 -2.00% ✗ $34.9K
Aug 17, 2025 Aug 19, 2025 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 46.3 -2,939 -2.46% ✗ $38.8K
Aug 17, 2025 Aug 19, 2025 Palleiko Benjamin L CEO Sell 42.5 -4,409 -1.16% ✗ $58.1K
Aug 11, 2025 Aug 13, 2025 Palleiko Benjamin L CEO Neutral 52.5 - 0.00% ✗ -
Jul 8, 2025 Jul 10, 2025 Palleiko Benjamin L CEO Sell 97.5 +54,521 17.30% ✗ $517.5K
Jul 8, 2025 Jul 10, 2025 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 97.5 +29,750 30.30% ✗ $474.7K
Jun 6, 2025 Jun 10, 2025 Palleiko Benjamin L CEO Sell 42.5 -7,169 -2.22% ✗ $104K
May 22, 2025 May 27, 2025 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 46.3 -2,146 -1.86% ✗ $24.3K
May 22, 2025 May 27, 2025 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 46.3 -1,926 -1.92% ✗ $21.8K
May 21, 2025 May 23, 2025 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 46.3 -2,689 -2.38% ✗ $31.9K
May 21, 2025 May 23, 2025 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 46.3 -2,317 -2.33% ✗ $27.5K
May 21, 2025 May 23, 2025 Palleiko Benjamin L CEO Sell 42.5 -9,999 -3.16% ✗ $118.7K
May 17, 2025 May 20, 2025 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 46.3 -2,600 -2.65% ✗ $30.8K
May 17, 2025 May 20, 2025 Palleiko Benjamin L CEO Sell 46.3 -3,808 -1.28% ✗ $45.1K
May 17, 2025 May 20, 2025 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 46.3 -2,776 -2.54% ✗ $32.9K
Apr 9, 2025 Apr 11, 2025 Venrock Healthcare Capital Partners III, L.P. 10% Owner Buy 65.0 +25,000 0.47% ✗ $235.5K
Mar 6, 2025 Mar 10, 2025 Palleiko Benjamin L CEO Sell 42.5 -6,669 -2.26% ✗ $79.8K
Feb 22, 2025 Feb 25, 2025 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 46.3 -2,394 -2.27% ✗ $24K
Feb 21, 2025 Feb 25, 2025 Palleiko Benjamin L CEO Neutral 52.5 - 0.00% ✗ -
Feb 22, 2025 Feb 25, 2025 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 46.3 -1,918 -2.00% ✗ $19.2K
Feb 21, 2025 Feb 25, 2025 Piekos Brian CFO Neutral 52.5 - 0.00% ✗ -
Feb 17, 2025 Feb 19, 2025 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 46.3 -2,601 -2.73% ✗ $25.6K
Feb 17, 2025 Feb 19, 2025 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 46.3 -3,125 -3.02% ✗ $30.7K
Feb 17, 2025 Feb 19, 2025 Palleiko Benjamin L CEO Sell 42.5 -5,104 -1.80% ✗ $50.1K
Feb 12, 2025 Feb 14, 2025 Venrock Healthcare Capital Partners III, L.P. 10% Owner Buy 92.5 +161,700 3.16% ✗ $1.5M
Feb 7, 2025 Feb 11, 2025 Venrock Healthcare Capital Partners III, L.P. 10% Owner Buy 85.0 +104,489 2.08% ✗ $967.1K
Jan 30, 2025 Feb 3, 2025 Venrock Healthcare Capital Partners III, L.P. 10% Owner Buy 85.0 +70,023 1.42% ✗ $621.6K
Feb 3, 2025 Venrock Healthcare Capital Partners III, L.P. 10% Owner Neutral 52.5 - 0.00% ✗ -
Dec 6, 2024 Dec 9, 2024 Palleiko Benjamin L CEO Sell 42.5 -7,627 -2.70% ✗ $74.4K
Nov 22, 2024 Nov 27, 2024 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 46.3 -2,187 -2.20% ✗ $21.6K
Nov 22, 2024 Nov 27, 2024 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 46.3 -1,963 -2.11% ✗ $19.4K
Nov 23, 2024 Nov 26, 2024 Reid Laurence Director Neutral 52.5 - 0.00% ✗ -
Nov 26, 2024 Reid Laurence Director Neutral 52.5 - 0.00% ✗ -
Nov 17, 2024 Nov 19, 2024 Palleiko Benjamin L CEO Sell 42.5 -14,400 -5.12% ✗ $133.3K
Nov 17, 2024 Nov 19, 2024 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 42.5 -7,192 -7.40% ✗ $66.6K
Nov 17, 2024 Nov 19, 2024 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 42.5 -8,077 -7.90% ✗ $74.8K
Oct 3, 2024 Oct 4, 2024 Fairey William Director Neutral 52.5 - 0.00% ✗ -
Oct 3, 2024 Oct 4, 2024 Pereira Brian JG Director Neutral 52.5 - 0.00% ✗ -
Oct 3, 2024 Oct 4, 2024 Stuart Nancy Director Neutral 52.5 - 0.00% ✗ -
Oct 3, 2024 Oct 4, 2024 Treanor Patrick Director Neutral 52.5 - 0.00% ✗ -
Oct 3, 2024 Oct 4, 2024 Unkart Edward W Director Neutral 52.5 - 0.00% ✗ -
Sep 9, 2024 Sep 11, 2024 Piekos Brian CFO Neutral 52.5 - 0.00% ✗ -
Sep 11, 2024 Piekos Brian CFO Neutral 52.5 - 0.00% ✗ -
Sep 6, 2024 Sep 10, 2024 Palleiko Benjamin L CEO Sell 42.5 -7,352 -2.85% ✗ $89.6K
Aug 22, 2024 Aug 26, 2024 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 46.3 -2,135 -2.49% ✗ $26.5K
Aug 22, 2024 Aug 26, 2024 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 46.3 -1,916 -2.19% ✗ $23.8K
Aug 17, 2024 Aug 21, 2024 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 42.5 -7,973 -8.97% ✗ $95.8K
Aug 17, 2024 Aug 21, 2024 Palleiko Benjamin L CEO Sell 42.5 -14,215 -5.54% ✗ $170.8K
Aug 17, 2024 Aug 21, 2024 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 42.5 -7,102 -7.76% ✗ $85.3K
Jun 6, 2024 Jun 10, 2024 Palleiko Benjamin L CEO Sell 42.5 -7,465 -3.22% ✗ $86.1K
May 22, 2024 May 24, 2024 Yea Christopher CHIEF DEVELOPMENT OFFICER Neutral 52.5 - 0.00% ✗ -
May 22, 2024 May 24, 2024 Audhya Paul K. CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
May 17, 2024 May 21, 2024 Feener Edward P. CHIEF SCIENTIFIC OFFICER Sell 42.5 -8,088 -9.99% ✗ $95.2K
May 17, 2024 May 21, 2024 Audhya Paul K. CHIEF MEDICAL OFFICER Sell 42.5 -13,175 -15.78% ✗ $155K
May 17, 2024 May 21, 2024 Palleiko Benjamin L CEO Sell 40.0 -21,959 -9.21% ✗ $258.3K
May 17, 2024 May 21, 2024 Yea Christopher CHIEF DEVELOPMENT OFFICER Sell 42.5 -11,610 -12.66% ✗ $136.6K
Apr 18, 2024 Apr 22, 2024 Fairey William Director Neutral 52.5 - 0.00% ✗ -